Cargando…
Current Status of Clinical and Genetic Screening of Hereditary Hemorrhagic Telangiectasia Families in Hungary
Autores principales: | Major, Tamás, Bereczky, Zsuzsanna, Gindele, Réka, Balogh, Gábor, Rácz, Benedek, Bora, László, Kézsmárki, Zsolt, Brúgós, Boglárka, Pfliegler, György |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432115/ https://www.ncbi.nlm.nih.gov/pubmed/34501220 http://dx.doi.org/10.3390/jcm10173774 |
Ejemplares similares
-
Founder Effects in Hereditary Hemorrhagic Telangiectasia
por: Major, Tamás, et al.
Publicado: (2021) -
Pitfalls of delaying the diagnosis of hereditary haemorrhagic
telangiectasia
por: Major, Tamás, et al.
Publicado: (2019) -
Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing
por: Gindele, Réka, et al.
Publicado: (2021) -
Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular Diseases
por: Bereczky, Zsuzsanna, et al.
Publicado: (2021) -
Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
por: Gindele, Réka, et al.
Publicado: (2021)